Subscribe Us

header ads

Recents

header ads

Ophthalmic Packaging Market Size, Growth, Demands Outlook and Forecasts to 2032

According to the research report, the global ophthalmic packaging market size is expected to touch USD 20.16 Billion by 2032, from USD 6.31 Billion in 2022, growing with a significant CAGR of 12.32% from 2023 to 2032.

Ophthalmic Packaging Market Size 2023 To 2032

Key Takeaways:

  • North America generated more than 37% of revenue share in 2022
  • Asia Pacific is expected to expand at the fastest CAGR from 2023 to 2032.
  • By Dose, the multi dose segment contributed more than 72% of revenue share in 2022.
  • By Type, the prescription segment registered more than 57% of revenue share in 2022.
  • By Material, the plastic segment recorded for the biggest market share in 2022.

The ophthalmic packaging report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global ophthalmic packaging in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global ophthalmic packaging market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global ophthalmic packaging during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/3072

This study covers a detailed segmentation of the global ophthalmic packaging market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global ophthalmic packaging market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • Amcor
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • SCHOTT AG
  • AptarGroup, Inc.
  • Akorn, Inc.
  • Johnson & Johnson Vision
  • Mitotech, SA
  • Bausch & Lomb Incorporated
  • AERIE PHARMACEUTICALS, INC.
  • Novartis AG
  • Merck Sharp & Dohme Corp.
  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • ALLERGAN
  • Santen Pharmaceutical Co.
  • Teva Pharmaceutical Industries Ltd.

Market Segmentation

By Dose

  • Multi Dose
  • Single Dose

By Type

  • OTC
  • Prescription

By Material

  • Glass
  • Plastic
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Research Methodology

The research methodology adopted by analysts for compiling the global ophthalmic packaging report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global ophthalmic packaging market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Ophthalmic Packaging Market 

5.1. COVID-19 Landscape: Ophthalmic Packaging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Ophthalmic Packaging Market, By Dose

8.1. Ophthalmic Packaging Market Revenue and Volume, by Dose, 2023-2032

8.1.1 Multi Dose

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Single Dose

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Ophthalmic Packaging Market, By Type

9.1. Ophthalmic Packaging Market Revenue and Volume, by Type, 2023-2032

9.1.1. OTC

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Prescription

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Ophthalmic Packaging Market, By Material 

10.1. Ophthalmic Packaging Market Revenue and Volume, by Material, 2023-2032

10.1.1. Glass

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Plastic

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Ophthalmic Packaging Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.1.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.1.4.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.4.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.1.5.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.5.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.2.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.2.4.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.4.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.2.5.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.5.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.2.6.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.6.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.2.7.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.7.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.3.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.3.4.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.4.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.3.5.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.5.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.3.6.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.6.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.3.7.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.7.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.4.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.4.4.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.4.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.4.5.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.5.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.4.6.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.6.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.4.7.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.7.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.5.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.5.4.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.4.3. Market Revenue and Volume Forecast, by Material (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Dose (2020-2032)

11.5.5.2. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.5.3. Market Revenue and Volume Forecast, by Material (2020-2032)

Chapter 12. Company Profiles

12.1. Amcor

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. West Pharmaceutical Services, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Gerresheimer AG

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. SCHOTT AG

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. AptarGroup, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Akorn, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Johnson & Johnson Vision

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Mitotech, SA

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Bausch & Lomb Incorporated

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. AERIE PHARMACEUTICALS, INC.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

Post a Comment

0 Comments